A large number of healthcare companies will be presenting drug data at the American Society of Gene & Cell Therapy Annual Meeting from May 16-19,
REGENXBIO Inc. (NASDAQ:RGNX), AVROBIO (AVRO), Athenex (ATNX), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Mustang Bio (MBIO), and Fortress Biotech (NASDAQ:FBIO). Bank of America has highlighted Rocket Pharmaceuticals (RCKT) for having some key readouts and clinical updates at ASGCT.
Moderna (NASDAQ:MRNA) will host its first in-person Science and Technology Day on May 17 for analysts and investors. The event will feature presentations with a focus on the company’s newest advances.
Caterpillar (CAT) is holding its annual investor day event next week with higher demand for commodities seen adding to the company’s backlog of machine orders.
New Relic (NEWR) will be hosting an Analyst Day on May 18 in conjunction with FutureStack 2022, the company’s annual customer and developer conference.
Other investor events on the calendar that stand out are the presentations from OneSpan (OSPN), Wingstop (NASDAQ:WING), Cowen (NASDAQ:COWN), Wix.com (NASDAQ:WIX), Wabash National Corporation (WNV), EPAM Systems (NYSE:EPAM), and Flywire Corporation (NASDAQ:FLYW). Analysts think guidance resets are more than likely with next week’s rush of investor events due to the shifting macroeconomic backdrop.